![Michael Nohaile](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Nohaile
Direktör/Styrelseledamot på
FULGENT GENETICS, INC.
Förmögenhet: 541 208 $ per 2026-09-30
Profil
Michael Nohaile is Chief Executive Officer at Prellis Biologics, Inc. since 2022 and Independent Director at Fulgent Genetics, Inc. since 2022.
Former roles include Director at Genoptix, Inc., General Manager-Molecular Diagnostics Business at Novartis Corp.
from 2007 to 2012, Partner at McKinsey & Co., Inc. from 2000 to 2007, Senior VP-Strategy, Commercialization & Innovation at Amgen, Inc. from 2012 to 2021, Global Head-Molecular Diagnostics at Novartis AG from 2008 to 2012, and Chief Scientific Officer at Generate Biomedicines, Inc. from 2021 to 2022.
Education includes undergraduate studies at Massachusetts Institute of Technology and a doctorate from the University of California, Berkeley.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
FULGENT GENETICS, INC. 0,08 % | 2026-05-14 | 24 578 ( 0,08 % ) | 541 208 $ | 2026-09-30 |
Aktiva positioner av Michael Nohaile
| Företag | Position | Start |
|---|---|---|
| FULGENT GENETICS, INC. | Direktör/Styrelseledamot | 2022-08-01 |
Prellis Biologics, Inc.
 Prellis Biologics, Inc. BiotechnologyHealth Technology Develops novel technology to bio print vascularized human tissues | Verkställande Direktör | 2022-08-11 |
Tidigare kända positioner av Michael Nohaile
| Företag | Position | Slut |
|---|---|---|
| GENERATE BIOMEDICINES, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-07-01 |
| AMGEN INC. | Företagsledare/Principal | 2021-02-01 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Företagsledare/Principal | 2012-11-01 |
| NOVARTIS AG | Företagsledare/Principal | 2012-11-01 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Företagsledare/Principal | 2007-01-01 |
Michael Nohailes utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
97
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genoptix, Inc.
 Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services | Health Services |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fulgent Genetics, Inc.
 Fulgent Genetics, Inc. Medical/Nursing ServicesHealth Services Provides genetic diagnostics services | Health Services |
Prellis Biologics, Inc.
Prellis Biologics, Inc. BiotechnologyHealth Technology Develops novel technology to bio print vascularized human tissues | Health Technology |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Operates as a clinical-stage generative biology company that provides biotechnology and drug design & development services | Health Technology |
